Mesalamine Tablet, Delayed Release
Product Images NDC 42291-489

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 42291-489). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

180 (489 18)

180 (489 18)
Mesalamine Delayed-Release Tablets, USP 800 mg oral tablets by AvKARE. The label indicates each film-coated delayed-release tablet contains 800 mg mesalamine. The bottle contains 180 tablets. Directions include not substituting one 800 mg tablet for two 400 mg tablets. Storage instructions and manufacturer information are also printed on the label.*
FDA Label Image

1 (Images 1)

1 (Images 1)
Chemical structure of Mesalamine showing a benzene ring with hydroxyl (OH), carboxyl (COOH), and amino (NH2) functional groups attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.